Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AcTIVE
2024-515010-40-00Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tranexamic acid and terlipressin in hemoptysis (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Proportion of patients with complete or partial resolution of hemoptysis without interventional procedures. Started Oct 2024; status: completed.
02
Drugs
tranexamic acidterlipressin
03
Conditions
hemoptysis
Beyond the preview
Go deeper on 2024-515010-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515010-40-00.